Regular Home Use of Dual-light Photodynamic Therapy on Oral Health in Adolescents Undergoing Fixed Orthodontic Treatment

NCT ID: NCT05825742

Last Updated: 2026-01-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-09-05

Study Completion Date

2025-03-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is designed to determine the efficacy of the Lumoral method on oral health in adolescents undergoing fixed orthodontic treatment. Improved supragingival plaque control can help to also sustain the subgingival plaque management in the long term. In addition, the device might have a photobiomodulation effect on periodontal tissues.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Orthodontic treatment is one of the most common dental treatments in children and adolescents. The use of fixed orthodontic appliances makes it difficult for the patients to keep their oral hygiene to an optimum level of cleanliness. Poor oral hygiene attracts significant plaque accumulation around the fixed orthodontic treatment appliances, and subsequent white spot lesions can occur rapidly, usually on the cervical and middle third of the buccal surfaces of bracketed teeth. Patients with the fixed orthodontic treatment appliances have an increased risk of caries and gingivitis.

The Lumoral is a CE-marked medical device developed to provide a potent, targeted antibacterial action on dental plaque in a home environment. The device mechanism of action is antibacterial photodynamic therapy (aPDT). The device is used by swishing a mouth rinse, which has a strong adherence to dental plaque. The plaque-adhered photoactive mouth rinse can be activated by a simple to use light applicator. Preliminary results have shown a promising anti-inflammatory response in addition to plaque reduction.

Forty (40) subjects undergoing fixed orthodontic treatment are randomized to the Lumoral treatment group or the control group. All subjects shall receive polishing and oral hygiene instruction. All patients shall be assessed for the clinical measurements including visible plaque index (VPI), bleeding on probing (BOP), and orthodontic plaque index (OPI) at baseline and at 4 weeks and 12 weeks after baseline. In addition, microbiological analyses shall be performed at baseline and at 12 weeks after baseline.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Orthodontic Appliance Complication Plaque, Dental Gingival Inflammation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Participants in two groups (Study group and Control group) shall receive instructions for standard oral hygiene. The same assessments are done for participants in both groups, and within the same time periods. The Study group will also be using the Lumoral Treatment device.
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

The participants, care providers, and investigators shall be masked before the first measurements. The randomization will be conducted after the first measurements.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Lumoral Treatment (Study group)

Subjects will receive detailed instructions for the use of Lumoral treatment -device. Subjects will be instructed to use the Lumoral treatment -device and follow the protocol once a day for two months and to keep a diary.

Subjects will receive the latest standard oral hygiene instructions according to the Swedish dental association's guidelines.

Group Type EXPERIMENTAL

Lumoral Treatment

Intervention Type DEVICE

Subjects will receive detailed instructions for the use of Lumoral treatment -device. Subjects will be instructed to use the Lumoral treatment -device and follow the protocol once a day for two months and to keep a diary.

Standard oral health instructions

Intervention Type OTHER

Subjects will receive the latest standard oral hygiene instructions according to the Swedish dental association's guidelines.

Standard of care (Control group)

Subjects will receive the latest standard oral hygiene instructions according to the Swedish dental association's guidelines.

Group Type OTHER

Standard oral health instructions

Intervention Type OTHER

Subjects will receive the latest standard oral hygiene instructions according to the Swedish dental association's guidelines.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Lumoral Treatment

Subjects will receive detailed instructions for the use of Lumoral treatment -device. Subjects will be instructed to use the Lumoral treatment -device and follow the protocol once a day for two months and to keep a diary.

Intervention Type DEVICE

Standard oral health instructions

Subjects will receive the latest standard oral hygiene instructions according to the Swedish dental association's guidelines.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age of 15-18 years old
* starting fixed orthodontic treatment
* good oral hygiene according to the dentist's assessment
* absence of periodontal disease and lack of oral lesion
* signed a written consent form, including information to caregivers.

Exclusion Criteria

* any chronic diseases
* medications that could influence the study (according to the dentists' assessment)
* active caries or a supposed high risk of caries
* gingivitis (bleeding on probing \>10%)
* use of antiseptic mouthwashes
* smoking
* use of antibiotics or anti-inflammatory therapy within 3 months before entering the study or during the study
* unable to cooperate with the protocol.
* pregnancy or lactation
Minimum Eligible Age

15 Years

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Helsinki

OTHER

Sponsor Role collaborator

Helsinki University Central Hospital

OTHER

Sponsor Role collaborator

Borgska Villans Specialisttandvård

UNKNOWN

Sponsor Role collaborator

Koite Health Oy

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ann-Marie Roos Jansåker, Professor

Role: PRINCIPAL_INVESTIGATOR

Borgska Villans Specialisttandvård

Tommi Pätilä, Docent

Role: STUDY_DIRECTOR

Koite Health

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Borgska Villans Specialisttandvård

Lund, , Sweden

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Sweden

References

Explore related publications, articles, or registry entries linked to this study.

Erbe C, Klees V, Braunbeck F, Ferrari-Peron P, Ccahuana-Vasquez RA, Timm H, Grender J, Cunningham P, Adam R, Wehrbein H. Comparative assessment of plaque removal and motivation between a manual toothbrush and an interactive power toothbrush in adolescents with fixed orthodontic appliances: A single-center, examiner-blind randomized controlled trial. Am J Orthod Dentofacial Orthop. 2019 Apr;155(4):462-472. doi: 10.1016/j.ajodo.2018.12.013.

Reference Type BACKGROUND
PMID: 30935601 (View on PubMed)

Nikinmaa S, Moilanen N, Sorsa T, Rantala J, Alapulli H, Kotiranta A, Auvinen P, Kankuri E, Meurman JH, Patila T. Indocyanine Green-Assisted and LED-Light-Activated Antibacterial Photodynamic Therapy Reduces Dental Plaque. Dent J (Basel). 2021 May 3;9(5):52. doi: 10.3390/dj9050052.

Reference Type BACKGROUND
PMID: 34063662 (View on PubMed)

Verrusio C, Iorio-Siciliano V, Blasi A, Leuci S, Adamo D, Nicolo M. The effect of orthodontic treatment on periodontal tissue inflammation: A systematic review. Quintessence Int. 2018;49(1):69-77. doi: 10.3290/j.qi.a39225.

Reference Type BACKGROUND
PMID: 29114647 (View on PubMed)

Walsh LJ, Healey DL. Prevention and caries risk management in teenage and orthodontic patients. Aust Dent J. 2019 Jun;64 Suppl 1:S37-S45. doi: 10.1111/adj.12671.

Reference Type BACKGROUND
PMID: 31144319 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

https://link.springer.com/article/10.1007/s41547-019-00056-9

Alaijah, F., Morsi, A., Nasher, R. et al. Photobiomodulation therapy in the treatment of periodontal disease: a literature review. Laser Dent Sci 3, 147-153 (2019)

https://www.fda.gov/media/75892/download

Levine JI. Medications that increase photosensititivity. FDA document Dec 1990.

https://bmcoralhealth.biomedcentral.com/articles/10.1186/s12903-019-0828-z

Linden J, Widström E \& Sinkkonen J (2019) Children and adolescents´ dental treatment in 2001-2013 in the Finnish public dental service. BMC Oral Health (2019) 19:131

https://doi.org/10.1371/journal.pone.0232775

Nikinmaa S, Alapulli H, Auvinen P, et al. (2020) Dual-light photodynamic therapy administered daily provides a sustained antibacterial effect on biofilm and prevents Streptococcus mutans adaptation. PLoS ONE 15(5)

https://doi.org/10.1016/j.parkreldis.2017.02.026

Pereira PAB, Aho VTE, Paulin L, et al., (2017) Oral and nasal microbiota in Parkinson's disease. Parkinsonism and Related Disorders 38: 61-67

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CLEAN-BRACKET

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.